Literature DB >> 11027329

Distinct cAMP response element-binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.

J Kim1, J Lu, P G Quinn.   

Abstract

Hormones and neurotransmitters rapidly change patterns of gene expression in target cells by activating protein kinases that phosphorylate and modify the activity of CREB and other transcription factors. Although CREB was initially characterized as mediating the response to cAMP, CREB phosphorylation and activation are stimulated by diverse extracellular signals and protein kinases in essentially all cells and tissues. CREB stimulates transcription through a constitutive activation domain (CAD), which interacts with the promoter recognition factor TFIID, and through a kinase-inducible domain (KID), when Ser-133 is phosphorylated. The present study provides new insight into the mechanism of activation by showing that each of the CREB domains contributes to transcription initiation by stimulating sequential steps in the transcription reaction. The CAD effectively assembled a polymerase complex, as evidenced by constitutive activation in vivo and stimulation of single-round transcription in vitro. In contrast, phosphorylation of the KID in CREB stimulated isomerization of the polymerase complex, as determined by abortive initiation, and promoter clearance and/or reinitiation, as measured by multiple rounds of transcription. Our results provide evidence for a new model for CREB-mediated induction through a concerted mechanism involving establishment of a polymerase complex by the CAD, followed by stimulation of isomerization, promoter clearance, and/or reinitiation by phosphorylated KID to enhance target gene transcription.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027329      PMCID: PMC17193          DOI: 10.1073/pnas.97.21.11292

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB.

Authors:  J A Ranish; N Yudkovsky; S Hahn
Journal:  Genes Dev       Date:  1999-01-01       Impact factor: 11.361

2.  Transcription reinitiation rate: a potential role for TATA box stabilization of the TFIID:TFIIA:DNA complex.

Authors:  D Yean; J D Gralla
Journal:  Nucleic Acids Res       Date:  1999-02-01       Impact factor: 16.971

Review 3.  Signaling routes to CREM and CREB: plasticity in transcriptional activation.

Authors:  D De Cesare; G M Fimia; P Sassone-Corsi
Journal:  Trends Biochem Sci       Date:  1999-07       Impact factor: 13.807

4.  The CREB constitutive activation domain interacts with TATA-binding protein-associated factor 110 (TAF110) through specific hydrophobic residues in one of the three subdomains required for both activation and TAF110 binding.

Authors:  E A Felinski; P G Quinn
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 5.  Common themes in assembly and function of eukaryotic transcription complexes.

Authors:  L Zawel; D Reinberg
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

6.  Functions of the N- and C-terminal domains of human RAP74 in transcriptional initiation, elongation, and recycling of RNA polymerase II.

Authors:  L Lei; D Ren; A Finkelstein; Z F Burton
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

7.  CREB is a regulatory target for the protein kinase Akt/PKB.

Authors:  K Du; M Montminy
Journal:  J Biol Chem       Date:  1998-12-04       Impact factor: 5.157

8.  Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators.

Authors:  D Saluja; M F Vassallo; N Tanese
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB.

Authors:  K Barton; N Muthusamy; M Chanyangam; C Fischer; C Clendenin; J M Leiden
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

10.  A tripartite array of transcription factor binding sites mediates cAMP induction of phosphoenolpyruvate carboxykinase gene transcription and its inhibition by insulin.

Authors:  D Yeagley; J M Agati; P G Quinn
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  6 in total

1.  The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB.

Authors:  E A Felinski; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  A quantitative analysis of transcriptionally active syncytiotrophoblast nuclei across human gestation.

Authors:  N M E Fogarty; T M Mayhew; A C Ferguson-Smith; G J Burton
Journal:  J Anat       Date:  2011-08-24       Impact factor: 2.610

3.  Recruitment of an RNA polymerase II complex is mediated by the constitutive activation domain in CREB, independently of CREB phosphorylation.

Authors:  E A Felinski; J Kim; J Lu; P G Quinn
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

4.  Regulation of the human SOX9 promoter by Sp1 and CREB.

Authors:  Sonsoles Piera-Velazquez; David F Hawkins; Mary Kate Whitecavage; David C Colter; David G Stokes; Sergio A Jimenez
Journal:  Exp Cell Res       Date:  2007-01-08       Impact factor: 3.905

5.  Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism.

Authors:  Séverine Boulon; Jean-Christophe Dantonel; Virginie Binet; Annick Vié; Jean-Marie Blanchard; Robert A Hipskind; Alexandre Philips
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

6.  Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB.

Authors:  Elena Ainbinder; Merav Revach; Orit Wolstein; Sandra Moshonov; Noam Diamant; Rivka Dikstein
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.